Search

Chronic sun exposure induces profound changes to the dermal extracellular matrix (ECM) resulting in the loss of fibrillin-rich microfibrils (FRM) [1] and fibrillar collagen [2]. The gold standard topical treatment for photoaged skin is all-trans retinoic acid (tRA) [3]. The ‘Manchester Patch-Test’ (MPT) assay was first developed in 2001 as a short-term, exaggerated-use patch test protocol to test the potential efficacy of topical anti-ageing products [4].

One of the most successful uses of nuclear energy, other than nuclear fission reactors, is the use of radioisotopes to provide a simple source for heat and electrical power in space applications. The alpha decay heat from suitable radioisotopes can be harnessed to heat instrumentation and generate electricity through thermoelectric generators. Within Europe, the feasibility of using americium (241Am) in such applications is being considered. Part of this study is to develop a way to access a stock of suitable material and the UK stockpile of separated civil plutonium dioxide, generated through reprocessing operations, is a rich source of americium. This paper summarises 5 years of development work performed to establish a way to separate americium from the plutonium dioxide in a safe and cost effective way, generating a high purity product with high recovery efficiency.

The dissolution of uranium or uranium-plutonium carbide fuel in nitric acid leads to ~50% carbon evolved as carbon dioxide, the remainder remains in the solution as soluble organics. These dissolved organic molecules interfere with the solvent extraction of uranium and plutonium by complexing to the actinide ions and decreasing the efficiency of their extraction. Experiments reported here describe two series of experiments assessing the uranium carbide dissolution liquor treatment by prolonged boiling and electrochemical oxidation. Plutonium losses to aqueous and solvent raffinates are observed for untreated liquors, highlighting that mineralisation of dissolved organics is necessary to reduce the complexing effects of organic acids to an extent that permit efficient operation of a solvent extraction process both in the first solvent use (considered here) and for maintaining solvent quality during industrial solvent reuse in the highly active cycle. Solution carbon analysis and 30% TBP solvent extraction batch tests of uranium and plutonium originating from dissolved uranium carbide liquors untreated and after treatment are compared. These experiments demonstrate the reprocessing of uranium carbides by direct dissolution coupled to a mineralisation process, can achieve near quantitative uranium and high plutonium recoveries (99.9%).

Background &amp, Aims: ARID1A is postulated to be a tumor suppressor gene owing to loss-of-function mutations in human pancreatic ductal adenocarcinomas (PDAC). However, its role in pancreatic pathogenesis is not clear despite recent studies using genetically engineered mouse (GEM) models. We aimed at further understanding of its direct functional role in PDAC, using a combination of GEM model and PDAC cell lines. Methods: Pancreas-specific mutant Arid1a-driven GEM model (Ptf1a-Cre, KrasG12D, Arid1af/f or &ldquo, KAC&rdquo, ) was generated by crossing Ptf1a-Cre, KrasG12D (&ldquo, KC&rdquo, ) mice with Arid1af/f mice and characterized histologically with timed necropsies. Arid1a was also deleted using CRISPR-Cas9 system in established human and murine PDAC cell lines to study the immediate effects of Arid1a loss in isogenic models. Cell lines with or without Arid1a expression were developed from respective autochthonous PDAC GEM models, compared functionally using various culture assays, and subjected to RNA-sequencing for comparative gene expression analysis. DNA damage repair was analyzed in cultured cells using immunofluorescence and COMET assay. Results: Retention of Arid1a is critical for early progression of mutant Kras-driven pre-malignant lesions into PDAC, as evident by lower Ki-67 and higher apoptosis staining in &ldquo, as compared to &ldquo, mice. Enforced deletion of Arid1a in established PDAC cell lines caused suppression of cellular growth and migration, accompanied by compromised DNA damage repair. Despite early development of relatively indolent cystic precursor lesions called intraductal papillary mucinous neoplasms (IPMNs), a subset of &ldquo, mice developed aggressive PDAC in later ages. PDAC cells obtained from older autochthonous &ldquo, mice revealed various compensatory (&ldquo, escaper&rdquo, ) mechanisms to overcome the growth suppressive effects of Arid1a loss. Conclusions: Arid1a is an essential survival gene whose loss impairs cellular growth, and thus, its expression is critical during early stages of pancreatic tumorigenesis in mouse models. In tumors that arise in the setting of ARID1A loss, a multitude of &ldquo, mechanisms drive progression.

Electrical power sources used in outer planet missions are a key enabling technology for data acquisition and communications. State–of-the-art power sources generate electricity from alpha decay of 238Pu via thermoelectric conversion. However, production of 238Pu requires specialist facilities including a nuclear reactor, a source of 237Np for target irradiation and hotcells to chemically separate neptunium and plutonium within the irradiated targets. These specialist facilities are expensive to build and operate, so naturally, a more economical alternative is attractive to the space industry. Within Europe 241Am is considered a promising alternative heat source for radioisotope thermoelectric generators (RTGs) and radioisotope heating units (RHUs) since, as a daughter product of 241Pu decay, 241Am exists in 1000 kgs quantities within the UK civil plutonium stockpile. A chemical separation process is required to extract the 241Am in a pure form and this paper describes the AMPPEX process (Americium and Plutonium Purification by Extraction), successfully developed over the past five years to isolate 241Am in high yield (> 99%) and to a high purity (> 99%). The process starts by dissolving plutonium dioxide in nitric acid with the aid of a silver(II) catalyst, which is generated electrochemically. The solution is then conditioned and fed to a PUREX type solvent extraction process, where the plutonium is separated from the americium and silver. The plutonium is converted back to plutonium dioxide and the americium is fed forward to a second solvent extraction step. Here the americium is selectively extracted leaving the silver in the aqueous phase. The americium is stripped from the solvent and recovered from solution as americium oxalate, which is calcined to give americium dioxide as the final product. This paper describes the development of the AMPPEX process over a series of six solvent extraction separation trials using centrifugal contactors. The technical underpinning reported here has allowed the design of a facility capable of producing 25-50 g of americium per day.

The International League of Dermatological Societies (ILDS), a global, not-for-profit organization representing 157 dermatological societies worldwide, has identified the consequences of skin aging as one of the most important grand challenges in global skin health. Reduced functional capacity and increased susceptibility of the skin with development of dermatoses such as dry skin, itching, ulcers, dyspigmentation, wrinkles, fungal infections, as well as benign and malignant tumors are the most common skin conditions in aged populations worldwide. Environmental (e.g., pollution) and lifestyle factors (e.g., smoking, sunbed use) negatively affect skin health. In turn altered appearance, dry skin, chronic wounds, and other conditions decrease general health and reduce the likelihood for healthy and active aging. Preventive skin care includes primary, secondary, and tertiary interventions. Continuous sun protection from early childhood onward is most important, to avoid extrinsic skin damage and skin cancer. Exposure to irritants, allergens, or other molecules damaging the skin must be avoided or reduced to a minimum. Public health approaches are needed to implement preventive and basic skin care worldwide to reach high numbers of dermatological patients and care receivers. Education of primary caregivers and implementation of community dermatology are successful strategies in resource-poor countries. Besides specialist physicians, nurses and other health care professionals play important roles in preventing and managing age-related skin conditions in developing as well as in developed countries. Healthy skin across the life course leads to better mental and emotional health, positive impact on social engagement, and healthier, more active, and productive lives.

Despite the documented risks associated with medical aesthetic procedures such as the administration of dermal fillers, the Government has failed to recommend the use of a mandatory register for cosmetic practitioners. Tamara Griffiths, consultant dermatologist, disagrees with this approach to regulation and strongly believes a mandatory register is immediately needed to protect patients

SummaryBackground Unwanted submental fat (SMF) is aesthetically unappealing, but methods of reduction are either invasive or lack evidence for their use. An injectable approach with ATX-101 (deoxycholic acid) is under investigation. Objectives To evaluate the efficacy and safety of ATX-101 for the reduction of unwanted SMF. Methods In this double-blind, placebo-controlled, phase III study, 363 patients with moderate/severe SMF were randomized to receive ATX-101 (1 or 2 mg cm−2) or placebo injections into their SMF at up to four treatment sessions ~28 days apart, with a 12-week follow-up. The co-primary efficacy endpoints were the proportions of treatment responders [patients with ≥ 1-point improvement in SMF on the 5-point Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)] and patients satisfied with their face and chin appearance on the Subject Self-Rating Scale (SSRS). Secondary endpoints included skin laxity, calliper measurements and patient-reported outcomes. Adverse events were monitored. Results Significantly more ATX-101 recipients met the primary endpoint criteria vs. placebo: on the clinician scale, 59·2% and 65·3% of patients treated with ATX-101 1 and 2 mg cm−2, respectively, were treatment responders vs. 23·0% for placebo (CR-SMFRS; P

Electrical power sources used in outer planet missions are a key enabling technology for data acquisition and communications. State–of-the-art power sources generate electricity from alpha decay of 238 Pu via thermoelectric conversion. However, production of 238 Pu requires specialist facilities including a nuclear reactor, a source of 237 Np for target irradiation and hotcells to chemically separate neptunium and plutonium within the irradiated targets. These specialist facilities are expensive to build and operate, so naturally, a more economical alternative is attractive to the industry. Within Europe 241Am is considered a promising alternative heat source for radioisotope thermoelectric generators (RTGs) and radioisotope heating units (RHUs). As a daughter product of 241 Pu decay, 241 Am exists in 1000 kgs quantities within the UK civil plutonium stockpile.A chemical separation process is required to extract the 241 Am in a pure form and this paper describes the AMPPEX process (Americium and Plutonium Purification by Extraction), successfully developed over the past five years to isolate 241 Am in high yield (> 99%) and to a high purity (> 99%).The process starts by dissolving plutonium dioxide in nitric acid with the aid of a silver(II) catalyst, which is generated electrochemically. The solution is then conditioned and fed to a PUREX type solvent extraction process, where the plutonium is separated from the americium and silver. The plutonium is converted back to plutonium dioxide and the americium is fed forward to a second solvent extraction step. Here the americium is selectively extracted leaving the silver in the aqueous phase. The americium is stripped from the solvent and recovered from solution as americium oxalate, which is calcined to give americium dioxide as the final product. This paper will describe the development of the separation process over a series of six solvent extraction separation trials using centrifugal contactors. The material produced (~ 4g 241 Am) was used to make ceramic pellets to establish the behaviour of americium oxide material under high temperature (1450°C) sintering conditions.The chemical separation process is now demonstrated at concentrations expected on the full scale facility taking this process to TRL 4-5.

Background.As facial appearance can be readily quantified and skin tissue easily accessed, they could be valuable tools for determining how biological mechanisms influence tissue degeneration with age and, consequently, human health and lifespan. It is unknown, however, whether appearance reflects disease risk or lifespan independently of factors already known to associate with both health and appearance.Methods.In a cross-sectional study, we compared the amount of skin wrinkling on a sun-protected site (upper inner arm) and the facial appearance of 261 offspring (mean age 63.2 y) of nonagenarian siblings with 253 age-matched controls (mean age 62.7 y), all with no reported disease history. We next examined whether any appearance features that significantly associated with familial longevity also associated with the Framingham cardiovascular disease (CVD) risk score. All analyses were adjusted for chronological age, smoking, photodamage, and body mass index.Results.Female and male offspring had reduced upper inner arm skin wrinkling (p =. 03 and p

We of the British Association of Dermatologists strongly believe that the advertising of cosmetic surgery should be controlled and limited.1 2 Regulation of these services and those who conduct them must also be extended to higher risk non-surgical procedures such as dermal fillers and laser because, like surgery, they can carry clinically significant health …